Skip to content

Study · Not a test of the peptide alone · 2002

2 results

Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism.

Bouloux P, Warne DW, Loumaye E

Fertility and sterility1 Feb 2002Cited by 60 (Europe PMC)

PMID11821082 (opens in a new tab)DOI10.1016/s0015-0282(01)02973-9 (opens in a new tab)PepBankPUB-11821082
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking hCG (human chorionic gonadotropin).

  1. 01HumanNot a test of hCG (human chorionic gonadotropin) aloneNon-randomized trialEfficacy outcome

    In evaluable men with isolated hypogonadotropic hypogonadism, hCG with rhFSH achieved spermatogenesis in 15 of 19 patients.

    In plain wordsIn men with isolated hypogonadotropic hypogonadism, hCG with rhFSH achieved sperm production in 15 of 19 evaluable patients.

    Peptide
    hCG (human chorionic gonadotropin)
    Outcome
    IncreaseSpermatogenesis
    Study

    n = 19

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Patients achieving spermatogenesis
    15 patients
    evaluable men receiving hCG with rhFSH

    Source sentences

    Summary
    Spermatogenesis was achieved in 15 of 19 patients who could be evaluated, 12 achieving a sperm concentration of > or =1.5 x 10(6)/mL.
    2 context sentences
    Summary · context
    Azoospermatic patients aged 16 to 48 years with IHH.
    Summary · context
    Patients received hCG for up to 6 months before 18 months of treatment with rhFSH.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

  2. 02HumanNot a test of hCG (human chorionic gonadotropin) aloneNon-randomized trialEfficacy outcome

    In evaluable men with isolated hypogonadotropic hypogonadism, hCG with rhFSH achieved sperm concentration of at least 1.5 x 10(6)/mL in 12 patients.

    In plain wordsWith hCG and rhFSH, 12 evaluable men reached a sperm concentration of at least 1.5 x 10(6)/mL.

    Peptide
    hCG (human chorionic gonadotropin)
    Outcome
    IncreaseSperm concentration threshold
    Study

    n = 19

    Outcome group
    Sex hormones and fertility · Reproductive and sexual health

    Measurements

    Patients achieving sperm concentration threshold
    12 patients
    evaluable men receiving hCG with rhFSH
    Sperm concentration threshold
    ≥ 1.5 x 10(6)/mL
    12 evaluable patients receiving hCG with rhFSH

    Source sentences

    Summary
    Spermatogenesis was achieved in 15 of 19 patients who could be evaluated, 12 achieving a sperm concentration of > or =1.5 x 10(6)/mL.
    2 context sentences
    Summary · context
    Azoospermatic patients aged 16 to 48 years with IHH.
    Summary · context
    Patients received hCG for up to 6 months before 18 months of treatment with rhFSH.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.